Results 121 to 130 of about 1,641 (192)

Delafloxacin, a New Miracle in Antibiotics Armamentarium for Bacterial Infections [PDF]

Journal of Bacteriology and Virology, 2019
Mohammad Saydur Rahman, Young-Sang Koh
openaire   +1 more source

A Randomized, Observer-Blinded, Active-Controlled, Phase IIIb Study to Compare IV/Oral Delafloxacin Fixed-Dose Monotherapy With Best Available Treatments in a Microbiologically Enriched Population With Surgical Site Infections: The DRESS Study. [PDF]

Open Forum Infect Dis
Belev N, Tein A, Mangialardi G, Nuti A, Marino Merlo G, Scartoni S, Bertolotti M, Lerro M, Margaritora S.   +8 more
europepmc   +1 more source

Highly fluorescent method for ultra-sensitive estimation of delafloxacin in human plasma: greenness assessment. [PDF]

BMC Chem
Salman BI.
europepmc   +1 more source

Correction: Molecular resistance mechanisms to newly approved antibiotics (2017-2025) in WHO priority pathogens. [PDF]

Front Microbiol
Frontiers Production Office.
europepmc   +1 more source

Temocillin: a therapeutic alternative in bone and joint infections due to third generation cephalosporin-resistant Enterobacterales? [PDF]

J Antimicrob Chemother
Piquart L, Goutelle S, Maillard M, Boisset S, Carricajo A, Tristan A, Ranc AG, Laurent F, Dupieux C.   +8 more
europepmc   +1 more source

UK Antimicrobial Registry: Virtual Registry-an innovative surveillance approach for monitoring the real-world use and effectiveness of newly licensed antimicrobials in Scotland. [PDF]

JAC Antimicrob Resist
Goswami C, Turgal E, Mueller T, Bennie M, Parr R, Jones GT, Seaton RA, Jenkins D, Baltas I, Sneddon J, Sandoe JAT, Garraghan F, Brown NM, Macfarlane GJ, Kurdi A.   +14 more
europepmc   +1 more source

Molecular Dynamics-Guided Repositioning of FDA-Approved Drugs for PD-L1 Inhibition with In Vitro Anticancer Potential. [PDF]

Int J Mol Sci
Jiang D, Yoou MS, Cho S, Choi Y.
europepmc   +1 more source

Synthesis of 2-Aryl-4-aminoquinazolines: Design, Molecular Docking, and In Vitro Assessment of Antibacterial and Cytotoxic Potential. [PDF]

Int J Mol Sci
Verdugo F, Braillon C, Mahjoub S, Castro-Alvarez A, Janel-Bintz R, Fechter P, Villa P, Jiménez CA, Donoso-Ruiz DA, Pérez-Fehrmann M, Kesternich V, Ortiz S, Nelson R.   +12 more
europepmc   +1 more source

Development of new antibiotics for the current public health bacterial threats [PDF]

, 2020
Bárbara Raquel Soares Nunes
core  

Omadacycline for the treatment of acute bacterial skin and skin structure infections: a systematic review and network meta-analysis. [PDF]

BMC Infect Dis
Kong WQ, Shu YF, Tang J, Li SQ, Zhong H, Zhang XY.   +5 more
europepmc   +1 more source